10. McCarthy CM, Loyo-Berrios N, Qureshi AA, Mullen E, Gordillo G, Pusic AL, Ashar BS, Sommers K, Clemens MW. Patient registry and outcomes for breast implants and anaplastic large cell lymphoma etiology and epidemiology (PROFILE): initial report of findings, 2012-2018. Plast Reconstr Surg 2019;143(3 Suppl):65S-73S.
11. Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK. Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg 2019;143(3 Suppl):30S-40S.
13. Campanale A, Spagnoli A, Lispi L, Boldrini R, Marletta M. The crucial role of surgical treatment in bia-alcl prognosis in early- and advanced-stage patients. Plast Reconstr Surg 2020;146:530e-538e.
16. Jones P, Mempin M, Hu H, Chowdhury D, Foley M, Cooter R, Adams WP Jr, Vickery K, Deva AK. The functional influence of breast implant outer shell morphology on bacterial attachment and growth. Plast Reconstr Surg 2018;142:837-849.
22. Rastogi P, Riordan E, Moon D, Deva AK. Theories of etiopathogenesis of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 2019;143(3 Suppl):23S-29S.
23. Marra A, Viale G, Pileri SA, Pravettoni G, Viale G, De Lorenzi F, Nolr F, Veronesi P, Curigliano G. Breast implant-associated anaplastic large cell lymphoma: a comprehensive review. Cancer Treat Rev 2020;84:101963.
28. Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J 2019;39(Suppl 1):S3-S13.